| 661/1507 | US=23 / Câncer Erban JK, Lau J. Systemic therapy for breast cancer: using toxicity data to inform decisions. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 373-94. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TERAPIA SISTEMICA; DADOS DE TOXICIDADE; TERAPIA HORMONAL; QUIMIOTERAPIA; TERAPIAS-ALVO; TOXICIDADE AGUDA; SEQUELAS |
| 662/1507 | US=23 / Câncer Morabito A, Piccirillo MC, Bryce J, Monaco K, De Feo G, Del Giudice A, Falasconi F, Perrone F. Chemotherapy for metastatic breast cancer patients who received adjuvant anthracyclines (an overview). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 395-414. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA METASTATICO; QUIMIOTERAPIA; ANTRACICLINAS ADJUVANTES; HER-2 |
| 663/1507 | US=23 / Câncer Frasci G, D'Aiuto G, Iodice G, Thomas R, D'Aiuto M, Comella G. Estrogen receptor-negative and HER-2/neu-positive locally advanced breast carcinoma: therapy with paclitaxel and granulocyte-colony stimulating factor. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 415-32. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CARCINOMA DE MAMA; ESTROGENIO; RECEPTOR-NEGATIVO; HER-2/NEU-POSITIVE; PACLITAXEL; COLONIAS DE GRANULOCITOS; RECEPTORES HORMONAIS; RESPOSTA A QUIMIOTERAPIA |
| 664/1507 | US=23 / Câncer Benson JR, Turner EH, Winters Z. Breast cancer: side effects of tamoxifen and anastrozole. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 433-57. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TAMOXIFENO; ANASTROZOL; TERAPIA ANTI-HORMONAL; CANCER DE MAMA AVANCADO; TERAPIA HORMONAL NEOADJUVANTE; TERAPIA HORMONAL ADJUVANTE; QUIMIOPREVENCAO; INIBIDORES DE AROMATASE |
| 665/1507 | US=23 / Câncer Shackney SE, Emlet DR, Schwartz R, Brown KA, Pollice AA, Smith CA. Breast cancer: expression of HER-2 and epidermal growth factor receptor as clinical markers for response to targeted therapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 459-82. ISBN 978-1-4020-8368-6. CANCER DE MAMA; EXPRESSAO DO RECEPTOR HER-2; FATOR DE CRESCIMENTO EPIDERMICO; RESPOSTA A TERAPIA-ALVO; IMUNOHISTOQUIMICA; HIBRIDACAO IN SITU FLUORESCENTE |
| 666/1507 | US=23 / Câncer Bafford AC, Garber JE, Chittenden A, Golshan M. Young breast cancer patients undergoing breast-conserving therapy: role of BRCA1 and BRCA2. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 483-91. ISBN 978-1-4020-8368-6. CANCER DE MAMA; PACIENTES JOVENS; TERAPIA CONSERVADORA DA MAMA; BRCA1; BRCA2 |
| 667/1507 | US=23 / Câncer Smith BD. Radiation therapy for older women with early breast cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 493-506. ISBN 978-1-4020-8368-6. |
| 668/1507 | US=23 / Câncer Tan XL, Popanda O, Chang-Claude J. Acute side effects of radiotherapy in breast cancer patients: role of DNA-repair and cell cycle control genes. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 507-28. ISBN 978-1-4020-8368-6. CANCER DE MAMA; RADIOTERAPIA; EFEITOS COLATERAIS; REPARO DO DNA; CELULAS GENES; CONTROLE DE CICLO |
| 669/1507 | US=23 / Câncer Kumar R, Lal N. 18F-Fluorodeoxyglucose/positron emission tomography in primary breast cancer: factors responsible for false-negative results. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 529-41. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TOMOGRAFIA POR EMISSAO DE POSITROS; 18F-FLUORODEOXIGLUCOSE; RESULTADOS FALSO-NEGATIVOS; TAMANHO TUMORAL; TIPO HISTOLOGICO; GRAU DO TUMOR; PADROES DE CRESCIMENTO DE TUMOR; ATIVIDADE PROLIFERATIVA; DENSIDADE DE VASOS SANGUINEOS DO TUMOR; HETEROGENEIDADE DO TECIDO; LESOES DE MAMA UNIFOCAL; LESOES DE MAMA MULTIFOCAL; RECEPTOR DE ESTROGENO; RECEPTOR DE PROGESTERONA; DENSIDADE DA MAMA; PROPAGACAO AXILAR; PROPAGACAO DISTANTE; NIVEIS DE GLICOSE NO SANGUE; TRANSPORTADORES DE GLICOSE; AQUISICAO DE DADOS; ANALISE DE DADOS |
| 670/1507 | US=23 / Câncer Boughey JC, Bedrosian I. Sentinel lymph node surgery during prophylactic mastectomy (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 543-56. ISBN 978-1-4020-8368-6. CANCER DE MAMA; LINFONODO SENTINELA; CIRURGIA; MASTECTOMIA PROFILATICA |
| 671/1507 | US=23 / Câncer Mack LA, Lindsay RL, Temple WJ. Breast conservation surgery: methods. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 557-68. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CIRURGIA; CONSERVACAO DA MAMA; METODOS CIRURGICOS |
| 672/1507 | US=23 / Câncer Peiró G. Lymph node-negative breast carcinoma: assessment of HER-2/neu gene status as prognostic value. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 569-81. ISBN 978-1-4020-8368-6. CANCER DE MAMA; LINFONODO NEGATIVO; CARCINOMA DE MAMA; AVALIACAO DA HER-2/NEU; STATUS GENETICO; VALOR PROGNOSTICO; SUPEREXPRESSAO DA PROTEINA; ELISA; IMUNOHISTOQUIMICA; MRNA; AMPLIFICACAO DO GENE |
| 673/1507 | US=23 / Câncer Oh JL. Multifocal or multicentric breast cancer: understanding its impact on management and treatment outcomes. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 583-7. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA MULTIFOCAL; CANCER DE MAMA MULTICENTRICO; RESSECCAO CIRURGICA; RADIOTERAPIA; QUIMIOTERAPIA |
| 674/1507 | US=35 / Biol/Mol Woodward WA, Cox JD. Molecular basis of radiation therapy. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 593-604. ISBN 978-1-4160-3703-3. CANCER. TERAPIA; RADIOTERAPIA; MORTE CELULAR; RADIOBIOLOGIA TRANSLATIONAL |
| 675/1507 | US=35 / Biol/Mol Posada JG Jr, Frankel AE. Monoclonal antibody therapy of cancer. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 671-8. ISBN 978-1-4160-3703-3. |
| 676/1507 | US=35 / Biol/Mol McCormick F, Korn WM. Gene therapy and oncolytic viruses. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 679-90. ISBN 978-1-4160-3703-3. VIRUS ONCOLITICOS; TERAPIA GENETICA; MORTE DAS CELULAS CANCERIGENAS |
| 677/1507 | US=35 / Biol/Mol Neckers L. Heat shock protein 90 and the proteasome: housekeeping proteins become novel molecular targets for cancer therapy. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 701-10. ISBN 978-1-4160-3703-3. PROTEINA DE CHOQUE TERMICO 90; PROTEASSOMA; ALVOS MOLECULARES; CANCER. TERAPIA; HSP90 |
| 678/1507 | US=23 / Câncer Raymond JS, Hogue CJR. Are breast cancer survivors at risk for developing other cancers?. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 589-600. ISBN 978-1-4020-8368-6. |
| 679/1507 | US=23 / Câncer Chagpar AB. Distant metastasis in elderly patients with breast cancer: prognosis with nodal status. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 601-8. ISBN 978-1-4020-8368-6. CANCER DE MAMA; METASTASES; PACIENTES IDOSOS; PROGNOSTICO; STATUS NODAL; AVALIACAO DO LINFONODO |
| 680/1507 | US=23 / Câncer Azria D, Belkacemi Y, Gligorov J, Ozsahin M. Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 609-23. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TAMOXIFENO; RADIOTERAPIA; FIBROSE SUBCUTANEA; HIPERSENSIBILIDADE |